CALX, TDC and LUMN jump after strong Q4 earnings, as AI infrastructure demand and bold platform bets set up potential 2026 breakouts despite valuation fears.
Source: https://www.zacks.com/stock/news/2861465/buy-these-3-mid-siz…
US chip stocks look a little unfazed despite the “sell America” trade supposedly being a new phase in the overall global economy.
DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.
CIEN, DG and CMC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 19, 2026.
